Searched for
PASC
New study to focus on treatment for long Covid that causes symptoms like brain fog, sleep disorderThe National Institutes of Health (NIH) will conduct studies to test possible treatments for long COVID, a condition that affects millions ...- Sleep disturbances common among people with long Covid: StudyThe retrospective analysis, published in Journal of General Internal Medicine, also identified risk factors for moderate to severe sleep di...
- 6 smallcap stocks with high ROE & consistent return on capital employedInvesting in small cap stocks is one of the toughest challenges for any investor. However, if an investor gets his decision right, the retu...
- The vast majority of cancer patients suffer from Covid-19 symptoms: StudyWomen undergoing cancer treatment are more vulnerable.
- This smallcap multibagger debutant has lost steam. Upside limited, say analystsOn Tuesday, the stock hit a low of Rs 2,250 on BSE, down 10 per cent. With this, the scrip has fallen 24 per cent from November 2021 high o...
- New research hints at 4 factors that may increase chances of long COVIDNow, a team of researchers who followed more than 200 patients for two to three months after their COVID diagnoses report that they have id...
- Buy Tatva Chintan Pharma Chem, target price Rs 3110: ICICI SecuritiesTatva Chintan Pharma Chem Ltd., incorporated in the year 1996, is a Small Cap company (having a market cap of Rs 5757.71 Crore) operating i...
- Tatva Chinta Pharma surges 11% as investors welcome industrial land buy in GujaratThe step, seen as an indicator of growth prospects by investors, send the company’s scrip shooting up to a high of Rs 2,599.90 on the Natio...
- Covid long-haulers may experience abnormal breathing, chronic fatigue: StudyMany long-haul COVID-19 patients have chronic fatigue syndrome and other breathing issues months after their initial diagnosis, according t...
- Tatva Chintan Pharma jumps 17%, hits 52-week high on strong Q2 showThe company's revenue from operations during the second quarter of the financial year 2021-22 (Q2FY22) surged 105.8 per cent YoY to Rs 123....
- Tatva Chintan lists at 95% premium over issue priceThe strong listing was in line with the recent trend, wherein market debutants have delivered 50-100 per cent returns at listing.
- Tatva Chintan Pharma Chem's Rs 500 cr IPO to open on July 16The offer size is Rs 500 crore, of which the company will issue fresh equity shares worth Rs 225 crore and offer for sale by promoters and ...
Load More
